Home / Treatments / Suction Assisted Lipectomy
Suction Assisted Lipectomy denials: what the review data shows
Independent reviewers have decided 18 published cases where an insurer denied Suction Assisted Lipectomy — and they overturned the insurer 38.9% of the time. A denial for Suction Assisted Lipectomy is a starting position, not a final answer.
Published decisions
18
2001–2026
Overturned
38.9%
7 denials reversed
Conditions behind suction assisted lipectomy denials
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Lipedema | 6 | 50% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 15 | 26.7% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 3 | 100% |
Typical time to a decision
21 days
Most land between 19 and 23 days
Handled as urgent
22.2%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for suction-assisted lipectomy to remove fat and other tissues of the trunk and arms. Lipedema is a chronic, progressive disorder of subcutaneous adipose tissue that usually affects the lower extremities. The benefits of suction lipectomy for the treatment of patients with lipedema are well established. These benefits include better ambulation and quality of life, and improvement in pain and tenderness. One study collected data from women who had undergone lipedema reduction surgery to determine if they experienced improvement in their quality of life, pain, and other measures.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for suction assisted lipectomy surgery on: upper extremity RT, upper extremity LT, trunk RT, trunk LT, and lower extremity. Per the medical records, the patient’s disease has progressed to stage 4 with secondary lymphedema, representing the most advanced stage, where functional limitations are most pronounced and surgical intervention offers the greatest benefit.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for lipedema surgery- suction assisted lipectomy to posterior hips and buttocks with excision of skin excess and thigh nodule, lateral thigh liposuction to address nodules in the lateral thigh, medial thigh and medial calf and excision of excess medial thigh skin are not reconstructive in nature for the treatment of this patient. One study stated that lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, patients also describe pain in the lower extremities, particularly with pressure, as well as easy bruising.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for additional lipedema reduction surgeries consisting of suction-assisted lipectomy of the (1) circumferential torso; (2) calves/ankles/upper arms; and (3) circumferential thighs. Sandhofer and colleagues report that lipedema is believed to affect 11% to 39% of the female Caucasian population worldwide, and that as many as 16 million women in the United States may be affected with the disorder. Warren Peled and Kappos state, “Lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Suction Assisted Lipectomywhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.